-- Approximately 5,500 Autoimmune PAP Patients in the U.S. Identified in the Updated Analysis that Leveraged a More Recent and Comprehensive Claims Data Source -- -- New England Journal of Medicine ...
A new study in The Lancet Public Health notes changes in the new and total use of medications after shortage announcements in ...
Prescription drug denials by private insurers in the United States jumped 25% from 2016 to 2023, according to a new analysis of more than 4 billion claims, a practice that has contributed to rising ...
PHILADELPHIA, Sept. 17, 2025 /PRNewswire/ -- NetDiligence®, a leading provider of cyber risk readiness and response solutions, has released its 2025 Cyber Claims Study, a data-driven analysis of ...
FDA officials plan to present data they claim links the Covid vaccine to 25 deaths in children at a CDC vaccine panel meeting ...
Insurance companies operating in Texas closed almost half the claims filed by homeowners last year without paying anything, part of a rising trend that is shifting more costs onto property owners, ...
Savara Inc. (the “Company”) (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced an increased estimate of autoimmune PAP diagnosed ...